Cadrenal Therapeutics, Inc. , a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapies, leading with tecarfarin, a new Vitamin K antagonist will ...
Bristol-Myers Squibb (NYSE:BMY), a global biopharmaceutical giant with a market capitalization of $120.8 billion, finds ...
“Studies have shown that healthcare utilization at the end of life is high, and patients receive aggressive medical care that ...
Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted Talphera's focus on ...
Scientists make disturbing new discovery after analyzing blood of vultures: 'The tip of the iceberg'
Despite California's statewide bans on toxic mouse and rat poison use, traces of these poisons are still being found in non-target wildlife species ... at least three were found to be exposed to ...
Target raised its fourth-quarter sales forecast Thursday after more consumers turned to its stores and website for holiday shopping — particularly on days known for deep discounts. The big-box ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback